[
    "{\"step_by_step_thinking\": \"Neoadjuvant Imatinib is a treatment used for locally advanced gastrointestinal stromal tumours (GISTs). Imatinib works by inhibiting certain proteins that contribute to cancer growth, one of which is the KIT protein. Mutations in the KIT gene can lead to an overactive KIT protein, which can contribute to the development and progression of GISTs. Therefore, analyzing for KIT mutations can help determine if a patient's GIST is likely to respond to Imatinib. Thus, KIT mutation analysis can indeed be a pathfinder in the treatment of locally advanced GISTs with Neoadjuvant Imatinib.\", \"answer_choice\": \"A. yes\"}"
]